
Suspected SARS patients hospitalised in French isolation units during the early SARS epidemic: The French experience
Author(s) -
B. Issartel,
Olivier Lesens,
Christian Chidiac,
Y Mouton,
D. Christmann,
D. Peyramond
Publication year - 2005
Publication title -
euro surveillance/eurosurveillance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.766
H-Index - 104
eISSN - 1560-7917
pISSN - 1025-496X
DOI - 10.2807/esm.10.03.00524-en
Subject(s) - myalgia , medicine , isolation (microbiology) , nausea , vomiting , pediatrics , covid-19 , transmission (telecommunications) , intensive care medicine , disease , infectious disease (medical specialty) , electrical engineering , microbiology and biotechnology , biology , engineering
During the SARS epidemic, many patients were screened according to WHO criteria but never went on to develop SARS. In May 2003, early in the epidemic, we conducted a retrospective study to describe suspected SARS patients hospitalised in France and compared them with documented cases of patients with SARS to evaluate the screening strategy. A total of 117 patients were studied. Only 3.4% had been in close contact with a SARS patient but 73.5% came from an affected area. 67.5% had fever and respiratory symptoms on their admission to hospital. 49.6% had fever and non specific symptoms. Clinical symptoms that were significantly more common among patients with SARS were fever, myalgia, dyspnoea, and nausea or vomiting. Presumed viral fever and respiratory tract infection were the most common diagnosis. Symptoms cannot be distinguished from an early stage of SARS confirming the usefulness of the WHO case definitions in isolation decision to avoid further transmission.